Yicura BioMed Holds Pre-Launch Preparation Meeting and IDMC Kick-off Meeting for ICVAX-201 Clinical ProjectMedia Outreach|19/11/2026oleh RRINEWSSICVAX® Phase II Clinical Study Enters Key Preparation Stage BEIJING, CHINA –
Yicura BioMed Advances Dual Capital and Industrial Strategy: Completes First Closing of Series B Financing Led by Gobi PartnersMedia Outreach|13/11/2026oleh RRINEWSSAdvancing Core Product ICVAX® for HIV & Immunotherapy Pipeline for Cancers HONG